News
NIH’s Steven Ferguson will be speaking at the Licensing Executives Society (LES) upcoming virtual seminar titled Industry, Universities, and Government – How to Work Together Through Contracts. This seminar will take place on June 25, 2024 from 10am-1pm EST. “The interface between institutions doing
![blank new placeholder image](/themes/custom/ott/images/news-card-placeholder.png)
In a recently released report, the NIH details its plans for Accelerating Technology Transfer and Commercialization in Support of High Growth Business. The Plan is a response to the October 28, 2011 Presidential Memorandum ( http://1.usa.gov/uHoAA4) that required federal agencies to streamline
![blank new placeholder image](/themes/custom/ott/images/news-card-placeholder.png)
Researchers have launched a clinical trial at the NIH Clinical Center to evaluate the drug candidate DEX-M74 as a treatment for a rare degenerative muscle disease, hereditary inclusion body myopathy (HIBM). DEX-M74, based on an NIH technology, is being developed through a collaboration between the
![blank new placeholder image](/themes/custom/ott/images/news-card-placeholder.png)
The NIH Office of Technology Transfer, Johns Hopkins University Technology Transfer and TTS Ltd., are pleased to announce that the 2012 edition of the Tech Transfer Summit North America (TTSNA) will take place on October 22-23, 2012. The conference will take place at at the Montgomery County